Document ID: chunk:federal_register_of_legislation:F2023C00019:clause:1_32
Version: federal_register_of_legislation:F2023C00019
Segment Type: clause
Provision Reference: sch 1 cl 32
Character Range: 48333–50114

32  Publication or dissemination of price information
 (1) Price information may only be published or disseminated by a retail pharmacy, an agent acting on behalf of a retail pharmacy (including a pharmacy marketing group), or a medical practitioner approved under section 92 of the National Health Act 1953.
 (2) Price information must not be published or disseminated in relation to a medicine listed in the pharmaceutical benefits scheme, and supplied through alternative arrangements under section 100 of the National Health Act 1953, other than dispensing fees for buprenorphine hydrochloride and methadone hydrochloride.
 (3) Price information may be published or disseminated by any means, other than the following:
 (a) radio or television transmission, including pay and streaming services;
 (b) digital or non-digital displays, including but not limited to displays:
 (i) in shopping malls outside individual pharmacies;
 (ii) in or on public transport;
 (iii) on billboards;
 (c) cinema advertising.
Online price information published or disseminated through a search function
 (4) Where price information for a medicine is published or disseminated through a search function included in an electronic sales system, the results of the search must only include:
 (a) if the search is conducted using the name of the medicine or part thereof—a list of relevant medicines of that name; or
 (b) if the search is conducted using an active ingredient or part thereof of the medicine—a list of relevant medicines in alphabetical order.
 (5) The following provisions of this Part do not apply to price information published or disseminated in accordance with subsection (4):
 (a) paragraph 33(1)(a) and subsections 33(2) and (3); and
 (b) paragraph 35(a); and
 (c) section 36.